The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Open accessAbstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that primarily strikes the elderly. Studies in both humans and animal models have linked the consumption of cholesterol and saturated fats with amyloid-β (Aβ) deposition and development of AD. Yet, these studies did not examine high fat diets in combination with reduced carbohydrate intake. Here we tested the effect of a high saturated fat/low carbohydrate diet on a transgenic mouse model of AD. Results: Starting at three months of age, two groups of female transgenic mice carrying the "London" APP mutation (APP/V717I) were fed either, a standard diet (SD) composed of high carbohydrate/low fat chow, or a ketogenic diet (KD) composed of very low carbohydrate/high saturated fat chow for 43 days. Animals fed the KD exhibited greatly elevated serum ketone body levels, as measured by β-hydroxybutyrate (3.85 ± 2.6 mM), compared to SD fed animals (0.29 ± 0.06 mM). In addition, animals fed the KD lost body weight (SD 22.2 ± 0.6 g vs. KD 17.5 ± 1.4 g, p = 0.0067). In contrast to earlier studies, the brief KD feeding regime significantly reduced total brain Aβ levels by approximately 25%. Despite changes in ketone levels, body weight, and Aβ levels, the KD diet did not alter behavioral measures. Conclusion: Previous studies have suggested that diets rich in cholesterol and saturated fats increased the deposition of Aβ and the risk of developing AD. Here we demonstrate that a diet rich in saturated fats and low in carbohydrates can actually reduce levels of Aβ. Therefore, dietary strategies aimed at reducing Aβ levels should take into account interactions of dietary components and the metabolic outcomes, in particular, levels of carbohydrates, total calories, and presence of ketone bodies should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several clinical studies have shown a positive effect of a ketogenic diet on patients with AD or mild cognitive impairment (MCI), consistent with preclinical results [87–91] (Table 1).”
From Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders (2022) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226 · cited 1×
“Background Alzheimer's disease (AD) is an age-associated neurodegenerative disease that is very common in the US, affecting up to 50% of people between the ages of 75 to 84 years [1].”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Calorie restriction, SIRT1 and metabolism: understanding longevity
Bordone, L., & Guarente, L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1616 · Cited by 1,038
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 2×
“The results from this analysis led the author to suggest that diets rich in saturated fats and cholesterol increased the risk of several types of dementia [5].”
BackgroundResultHypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 783
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?
Corbo, R. M., & Scacchi, R. (1999) · Annals of Human Genetics · doi:10.1046/j.1469-1809.1999.6340301.x · Cited by 653
Cited by
Sorted by citations
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Nagpal, R., Neth, B. J., Wang, S., Craft, S., & Yadav, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.032 · Cited by 653
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 633
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 584
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548
Self-citationLipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
Stafstrom, C. E., & Rho, J. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00059 · Cited by 448
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 412
Neuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 387
The Ketogenic Diet: One Decade Later
Freeman, J. M., Kossoff, E. H., & Hartman, A. L. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2447 · Cited by 364
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363
Dietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K. N., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 370
Ketone Bodies as a Therapeutic for Alzheimer's Disease
Henderson, S. T. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.004 · Cited by 327
Self-citationKetogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 326
Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
Ma, D., Wang, A. C., Parikh, I. J., Green, S. J., Hoffman, J. D., Chlipala, G. E., Murphy, M. P., Sokola, B. S., Bauer, B., Hartz, A. M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25190-5 · Cited by 315
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Chandra, S., Sisodia, S. S., & Vassar, R. J. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00595-7 · Cited by 278
Ketogenic diets, mitochondria, and neurological diseases
Gano, L. B., Patel, M., & Rho, J. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r048975 · Cited by 291
Kim, D. Y., Hao, J., Liu, R.-L., Turner, G., Shi, F.-D., & Rho, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035476 · Cited by 261
Ota, M., Matsuo, J., Ishida, I., Takano, H., Yokoi, Y., Hori, H., Yoshida, S., Ashida, K., Nakamura, K., Takahashi, T., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.048 · Cited by 276
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
Shippy, D. C., Wilhelm, C. R., Viharkumar, P. A., Raife, T. J., & Ulland, T. K. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01948-5 · Cited by 266
Clinical Aspects of the Ketogenic Diet
Hartman, A. L., & Vining, E. P. G. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00914.x · Cited by 246
The ketogenic diet: Uses in epilepsy and other neurologic illnesses
Barañano, K. W., & Hartman, A. L. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0043-8 · Cited by 239
Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse
Frère, S. G. A., & Slutsky, I. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.028 · Cited by 242
Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury
Prins, M. L. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600543 · Cited by 229
Volek, J. S., & Feinman, R. D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-31 · Cited by 223
Mitochondria: The ketogenic diet—A metabolism-based therapy
Vidali, S., Aminzadeh-Gohari, S., Lambert, B., Rutherford, T., Sperl, W., Kofler, B., & Feichtinger, R. G. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.022 · Cited by 221
Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014) · BioMed Research International · doi:10.1155/2014/474296 · Cited by 221
The Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 245
Neth, B. J., Mintz, A., Whitlow, C. T., Jung, Y., Sai, K. K. S., Register, T. C., Kellar, D., Lockhart, S. N., Hoscheidt, S. M., Maldjian, J. A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.015 · Cited by 219
D-beta-hydroxybutyrate extends lifespan in C. elegans
Edwards, C., Canfield, J., Copes, N., Rehan, M., Lipps, D., & Bradshaw, P. C. (2014) · Aging · doi:10.18632/aging.100683 · Cited by 209
Fernando, W. M. A. D. B., Martins, I. J., Goozee, K. G., Brennan, C. S., Jayasena, V., & Martins, R. N. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001452 · Cited by 200
Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders
Horn, J., Mayer, D. E., Chen, S., & Mayer, E. A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01922-0 · Cited by 193
Ketogenic Diets: An Update for Child Neurologists
Kossoff, E. H., Zupec‐Kania, B., & Rho, J. M. (2009) · Journal of Child Neurology · doi:10.1177/0883073809337162 · Cited by 183
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis
Hasan‐Olive, M. M., Lauritzen, K. H., Ali, M., Rasmussen, L. J., Storm‐Mathisen, J., & Bergersen, L. H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2588-6 · Cited by 185
Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2
Graff, E. C., Fang, H., Wanders, D., & Judd, R. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.001 · Cited by 187
Clinical review: Ketones and brain injury
White, H. T., & Venkatesh, B. (2011) · Critical Care · doi:10.1186/cc10020 · Cited by 175
Dąbek, A., Wojtala, M., Pirola, L., & Balcerczyk, A. (2020) · Nutrients · doi:10.3390/nu12030788 · Cited by 187
Hypometabolism as a therapeutic target in Alzheimer's disease
Costantini, L. C., Barr, L. J., Vogel, J. L., & Henderson, S. T. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s16 · Cited by 162
Self-citationNeuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity
Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 159
Whittaker, D. S., Akhmetova, L., Carlin, D., Romero, H., Welsh, D. K., Colwell, C. S., & Desplats, P. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.014 · Cited by 147
Brownlow, M. L., Benner, L., D’Agostino, D. P., Gordon, M. N., & Morgan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075713 · Cited by 153
The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
Broom, G. M., Shaw, I. C., & Rucklidge, J. J. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.003 · Cited by 151
Xu, Q., Zhang, Y., Zhang, X., Liu, L., Zhou, B., Mo, R., Li, Y., Li, H., Li, F., Yang, T., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.017 · Cited by 136
Obesity, leptin, and Alzheimer's disease
Lee, E. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06274.x · Cited by 126
Brain Metabolic Alterations in Alzheimer’s Disease
Ardanaz, C. G., Ramírez, M. J., & Solas, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073785 · Cited by 135
Ketogenic Diets for Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0666-8 · Cited by 137
Fatty acids and their therapeutic potential in neurological disorders
Lei, E., Vacy, K., & Boon, W. C. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.02.014 · Cited by 128
Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents
Streijger, F., Plunet, W. T., Lee, J. H. T., Liu, J., Lam, C. K., Park, S., Hilton, B. J., Fransen, B. L., Matheson, K. A. J., Assinck, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078765 · Cited by 117
Wilson, J. M., Lowery, R. P., Roberts, M. D., Sharp, M. H., Joy, J. M., Shields, K. A., Partl, J. M., Volek, J. S., & D'Agostino, D. P. (2020) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000001935 · Cited by 89
Kong, G., Huang, Z., Ji, W., Wang, X., Liu, J., Wu, X., Huang, Z., Li, R., & Zhu, Q. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5192 · Cited by 113
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 117
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 116
McPherson, P. A. C., & McEneny, J. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0112-4 · Cited by 106
Jang, J., Kim, S. R., Lee, J. E., Lee, S.-Y., Son, H. J., Choe, W., Yoon, K., Kim, S. S., Yeo, E., & Kang, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010124 · Cited by 116
Mitochondrial respiration as a target for neuroprotection and cognitive enhancement
Gonzalez-Lima, F., Barksdale, B. R., & Rojas, J. C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.010 · Cited by 105
Napoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 100
Dietary Therapies for Epilepsy
Kossoff, E. H., & Wang, H.-S. (2013) · Biomedical Journal · doi:10.4103/2319-4170.107152 · Cited by 100
Chatterjee, P., Fernando, M. G., Fernando, B., Dias, C. B., Shah, T. M., Silva, R., Williams, S., Pedrini, S., Hillebrandt, H., Goozee, K. G., et al. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111209 · Cited by 103
Sussman, D., Germann, J., & Henkelman, R. M. (2014) · Brain and Behavior · doi:10.1002/brb3.300 · Cited by 102
D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
Lim, S., Chesser, A. S., Grima, J. C., Rappold, P. M., Blum, D. L., Przedborski, S., & Tieu, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024620 · Cited by 94
Comorbidities in Neurology: Is adenosine the common link?
Boison, D., & Aronica, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.031 · Cited by 97
Beckett, T. L., Studzinski, C. M., Keller, J. N., Murphy, M. P., & Niedowicz, D. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.046 · Cited by 94
Vinciguerra, F., Graziano, M., Hagnäs, M. P., Frittitta, L., & Tumminia, A. (2020) · Nutrients · doi:10.3390/nu12041019 · Cited by 92
Global Metabolic Shifts in Age and Alzheimer’s Disease Mouse Brains Pivot at NAD + /NADH Redox Sites
Dong, Y., & Brewer, G. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190408 · Cited by 93
The effects of the ketogenic diet on behavior and cognition
Hallböök, T., Ji, S., Maudsley, S. R., & Martin, B. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.04.017 · Cited by 92
Role of diet and exercise in aging, Alzheimer’s disease, and other chronic diseases
Khemka, S., Reddy, A., Garcia, R. I., Jacobs, M., Reddy, R. P., Roghani, A. K., Pattoor, V., Basu, T., Sehar, U., & Reddy, P. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102091 · Cited by 88
The Expanding Role of Ketogenic Diets in Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Brain Sciences · doi:10.3390/brainsci8080148 · Cited by 92
Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation
Offermanns, S., & Schwaninger, M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.002 · Cited by 91
Chu, C., Yu, L., Qi, G., Mi, Y., Wu, W., Lee, Y. K., Zhai, Q., Tian, F., & Chen, W. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104556 · Cited by 87
The Combined Influences of Exercise, Diet and Sleep on Neuroplasticity
Pickersgill, J. W., Turco, C. V., Ramdeo, K. R., Rehsi, R. S., Foglia, S. D., & Nelson, A. J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.831819 · Cited by 92
Ciavardelli, D., Piras, F., Consalvo, A., Rossi, C., Zucchelli, M., Ilio, C. D., Frazzini, V., Caltagirone, C., Spalletta, G., & Sensi, S. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.005 · Cited by 81
Ketogenic Diets and Exercise Performance
Harvey, K. L., Holcomb, L. E., & Kolwicz, S. C. (2019) · Nutrients · doi:10.3390/nu11102296 · Cited by 92
Studzinski, C. M., MacKay, W. A., Beckett, T. L., Henderson, S. T., Murphy, M. P., Sullivan, P. G., & Burnham, W. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.005 · Cited by 82
Self-citationOmar, S. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112797 · Cited by 82
Effect of a four-week ketogenic diet on exercise metabolism in CrossFit-trained athletes
Durkalec‐Michalski, K., Nowaczyk, P. M., & Siedzik, K. (2019) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-019-0284-9 · Cited by 81
Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia.
Al-Zaid, N. S., Dashti, H. M., Mathew, T. C., & Juggi, J. S. (2007) · Acta Cardiologica · doi:10.2143/ac.62.4.2022282 · Cited by 72
Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration
Tai, K., Nguyen, N., Pham, L., & Truong, D. D. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0050-7 · Cited by 73
Are ketogenic diets promising for Alzheimer’s disease? A translational review
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton‐Liger, F., & Paquet, C. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00615-4 · Cited by 71
Metabolism and epilepsy: Ketogenic diets as a homeostatic link
Masino, S. A., & Rho, J. M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.049 · Cited by 72
Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease
Thaipisuttikul, P., & Galvin, J. E. (2012) · Clinical Practice · doi:10.2217/cpr.12.3 · Cited by 70
Jakimovski, D., Guan, Y., Ramanathan, M. K., Weinstock‐Guttman, B., & Zivadinov, R. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2018-0046 · Cited by 77
Ketogenic Diet for the Treatment and Prevention of Dementia: A Review
Davis, J. J., Fournakis, N. A., & Ellison, J. M. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720901785 · Cited by 73
Ruskin, D. N., & Masino, S. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00033 · Cited by 67
Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men
Kraeuter, A.-K., Phillips, R., & Sarnyai, Z. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109913 · Cited by 67
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, S., Bhalerao, A., Powers, M., Gonzalez, M., Mancuso, S., & Cucullo, L. (2023) · Cells · doi:10.3390/cells12162019 · Cited by 65
Ketone Bodies Promote Amyloid-β1–40 Clearance in a Human in Vitro Blood–Brain Barrier Model
Versele, R., Corsi, M., Fuso, A., Sevin, E., Businaro, R., Gosselet, F., Fénart, L., & Candela, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030934 · Cited by 66
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application
Malinowska, D., & Żendzian‐Piotrowska, M. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/6666171 · Cited by 75
Sussman, D., Ellegood, J., & Henkelman, R. M. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-198 · Cited by 63
Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling
Warren, E. C., Dooves, S., Lugarà, E., Damstra‐Oddy, J., Schaf, J., Heine, V. M., Walker, M. C., & Williams, R. S. B. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008980117 · Cited by 66
Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61
Loos, B., Klionsky, D. J., & Wong, E. S. P. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.001 · Cited by 64
Evidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 64
Kong, G., Liu, J., Li, R., Lin, J., Huang, Z., Zhou, Y., Wu, X., Huang, Z., Zhu, Q., & Wu, X. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03156-2 · Cited by 58
Metadata
- Authors
- Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Henderson, Samuel T
- Venue
- Nutrition & Metabolism
- Published
- 2005-10-17
- Volume
- 2
- Issue
- 1
- Pages
- 28-28
- ISSN
- 1743-7075 (ISSN-L)
- PMC
- PMC1282589
- OpenAlex
- W2109680432
- Cited by
- 307
- References
- 40
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 12 · 2023: 22 · 2022: 36 · 2021: 23 · 2020: 36 · 2019: 24 · 2018: 15 · 2017: 15 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 13
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Nutrition & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- ketogenic diet, Alzheimer's disease, amyloid-beta, Aβ40, amyloid-beta 42, high saturated fat diet, low-carbohydrate diet, ketone bodies, beta-hydroxybutyrate, dietary intervention, cholesterol, weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review